CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE capsule

Nchi: Marekani

Lugha: Kiingereza

Chanzo: NLM (National Library of Medicine)

Viambatanisho vya kazi:

CHLORDIAZEPOXIDE HYDROCHLORIDE (UNII: MFM6K1XWDK) (CHLORDIAZEPOXIDE - UNII:6RZ6XEZ3CR), CLIDINIUM BROMIDE (UNII: 91ZQW5JF1Z) (CLIDINIUM - UNII:BO76JF850N)

Inapatikana kutoka:

Marlex Pharmaceuticals Inc

INN (Jina la Kimataifa):

CHLORDIAZEPOXIDE HYDROCHLORIDE

Tungo:

CHLORDIAZEPOXIDE HYDROCHLORIDE 5 mg

Njia ya uendeshaji:

ORAL

Dawa ya aina:

PRESCRIPTION DRUG

Matibabu dalili:

Based on a review of this drug by the National Academy of Sciences – National Research Council and/or other information, FDA has classified the indications as follows: "Possibly" effective: as adjunctive therapy in the treatment of peptic ulcer and in the treatment of the irritable bowel syndrome (irritable colon, spastic colon, mucous colitis) and acute enterocolitis. Final classification of the less-than-effective indications requires further investigation. Chlordiazepoxide HCl and Clidinium Bromide Capsules are contraindicated in the presence of glaucoma (since the anticholinergic component may produce some degree of mydriasis) and in patients with prostatic hypertrophy and benign bladder neck obstruction. It is contraindicated in patients with known hypersensitivity to Chlordiazepoxide Hydrochloride and/or Clidinium Bromide. Withdrawal symptoms, similar in character to those noted with barbiturates and alcohol (convulsions, tremor, abdominal and muscle cramps, vomiting and sweating), have occurred fo

Idhini hali ya:

unapproved drug other

Tabia za bidhaa

CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE- CHLORDIAZEPOXIDE
HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULE
MARLEX PHARMACEUTICALS INC
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLINDINIUM BROMIDE CAPSULES
CHLORDIAZEPOXIDE HCL 5 MG/
CLIDINIUM BROMIDE 2.5 MG CAPSULES
R ONLY
DESCRIPTION
Chlordiazepoxide HCl and Clidinium Bromide combines in a single
capsule formulation the antianxiety
action of Chlordiazepoxide Hydrochloride and the
anticholinergic/spasmolytic effects of Clidinium
Bromide.
Each Chlordiazepoxide HCl and Clidinium Bromide Capsule for oral
administration contains 5 mg
Chlordiazepoxide Hydrochloride and 2.5 mg Clidinium Bromide. Each
capsule also contains D&C
Yellow #10, FD&C Green #3, gelatin, lactose, starch, talc, and
titanium dioxide.
Chlordiazepoxide Hydrochloride is a versatile, therapeutic agent of
proven value for the relief of
anxiety and tension. It is indicated when anxiety, tension or
apprehension are significant components of
the clinical profile. It is among the safer of the effective
psychopharmacologic compounds.
Chlordiazepoxide Hydrochloride is
7-chloro-2-methylamino-5-phenyl-3H-1, 4-benzodiazepine 4-
oxide hydrochloride. A colorless, crystalline substance, it is soluble
in water. It is unstable in solution
and the powder must be protected from light. The molecular weight is
336.22. The structural formula of
Chlordiazepoxide Hydrochloride is as follows:
Clidinium Bromide is 3-hydroxy-1-methylquinuclidinium bromide
benzilate, a synthetic anticholinergic
agent which has been shown in experimental and clinical studies to
have a pronounced antispasmodic
and antisecretory effect on the gastrointestinal tract. Structurally
Clidinium Bromide is:
X
ANIMAL PHARMACOLOGY
Chlordiazepoxide Hydrochloride has been studied extensively in many
species of animals and these
studies are suggestive of action on t